March 4, 2019What's New
Neurology and psychiatry have arrived at Target Health.
Many years ago we wrote several study reports for a major pharmaceutical company evaluating a novel treatment for depression. Since that that time and most recently, we have expanded our portfolio and knowledge in the following indications:
2. Alzheimer's disease
5. Huntington's disease
7. Progressive Supranuclear Palsy
9. Severe Bipolar Depression
10. Tourette's syndrome
11. Traumatic Brain Injury
For more information about Target Health, contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Also visit the Target Health Eating Website to see all of the fantastic recipes since 2012.
Joyce Hays, Founder and Editor in Chief of On Target
Jules Mitchel, Editor